Yahoo
NYSE - Nasdaq Real Time Price USD

CVS Health Corporation (CVS)

90.42 +0.47 (+0.52%)
As of 12:37:36 PM EDT. Market Open.
Trade CVS on Coinbase

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
Name Title Pay Exercised Year Born
Mr. J. David Joyner CEBS
CEO, President & Chairman 6.65M -- 1965
Mr. Brian O. Newman
Executive VP & CFO 2.82M -- 1969
Mr. Tilak Mandadi
EVP of Ventures and Chief Experience & Technology Officer 3.98M -- 1964
Mr. Prem S. Shah Pharm.D
Executive VP & Group President 4.38M 3.76k 1980
Mr. Steven Hale Nelson M.B.A.
Executive VP & President of Aetna 4.34M -- 1959
Mr. James David Clark
Senior VP, Controller & Chief Accounting Officer -- -- 1965
Mr. David A. Falkowski
Executive VP & Chief Compliance Officer -- -- --
Mr. Samrat S. Khichi Esq.
Executive VP of Corporate Affairs & Chief Legal Officer 3.39M -- 1967
Ms. Heidi B. Capozzi
Executive VP & Chief People Officer 1.85M -- 1970
Mr. Gustavo A. Giraldo
Head of Markets of Healthcare Benefits -- -- 1972

CVS Health Corporation

One CVS Drive
Woonsocket, RI 02895
United States
401 765 1500 https://www.cvshealth.com
Sector: 
Healthcare
Industry: 
Healthcare Plans
Full Time Employees: 
219,000

Description

CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

Corporate Governance

CVS Health Corporation’s ISS Governance QualityScore as of October 1, 2026 is 4. The pillar scores are Audit: 8; Board: 8; Shareholder Rights: 1; Compensation: 6.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 2, 2026 at 12:00 AM UTC

Dividend Date

November 4, 2026 at 12:30 PM UTC

CVS Health Corporation Earnings Date

Recent Events

October 22, 2026 at 12:00 AM UTC

Ex-Dividend Date

August 17, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 5, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 23, 2026 at 12:00 AM UTC

11-K: Annual report of employee stock purchase

May 22, 2026 at 12:00 AM UTC

S-8: Offering Registrations

May 18, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 6, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 3, 2026 at 12:00 AM UTC

DEF 14A: Proxy Statements

March 19, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 10, 2026 at 12:00 AM UTC

10-K: Periodic Financial Reports

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: